• The national cheese contract is expected to generate about $130 million in added sales per annum.
    The national cheese contract is expected to generate about $130 million in added sales per annum.
Close×

Murray Goulburn has signed a five-year national private label contract to supply Coles-brand Australian cheese.

The move is part of MG’s ongoing push to secure critical mass in Australia's dairy foods market.

MG said it would invest up to $145 million to significantly increase its ‘ready-to-serve’ cheese capacity and capabilities at its new consumer cheese plant in Cobram in Northern Victoria.

Managing director Gary Helou said MG would use “world-leading technology” for processing and packaging the blocks, slices, snacking and shredded cheese.

The announcement follows the landmark 10-year partnership MG commenced with Coles in 2014 to supply daily pasteurised milk for Coles private label brands in Victoria and NSW.

The national cheese contract will generate approximately $130 million in additional sales per annum.

Helou said MG was pursuing a growth and value creation strategy to deliver profitable growth and insulation from the challenges of volatile global dairy commodity prices.

“As part of this we are ramping up our manufacturing capability and capacity to produce and market a wide range of Australian made ‘ready-to-consume’ dairy foods for our domestic and international markets,” he said.

“This additional Coles business complements our investment strategy to build a state-of-the-art supply chain and adds to our critical mass here in Australia, as we look to substantially grow our business internationally."

Food & Drink Business

Australia’s first social enterprise bakery, The Bread & Butter Project, has graduated its latest group of bakers, with its largest ever cohort marking the program’s 100th graduate.

The University of Sydney and Peking University have launched a Joint Centre for Food Security and Sustainable Agricultural Development, which will support research into improving the sustainability and security of food systems in Australia and China.

Sydney-based biotech company, All G, has secured regulatory approval in China to sell recombinant (made from microbes, not cows) lactoferrin. CEO Jan Pacas says All G is the first company in the world to receive the approval, and recombinant human lactoferrin is “next in line”.